Please Wait...

Harry Genant

Translation skills

Main profile

Harry K. Genant
Chairman, Emeritus

Harry K. Genant is a co-founder of Synarc and Professor Emeritus of Radiology, Orthopedic Surgery, Medicine, and Epidemiology at the University of California San Francisco. While at UCSF, he founded the Osteoporosis and Arthritis Research Group, which has been widely acclaimed as a leading source of research in noninvasive imaging methods applied to patients with osteoporosis, arthritis, and orthopedics. He is currently a member of the Synarc board of directors and a senior consultant to the company.

Dr. Genant received his medical degree from Northwestern University in Chicago, Illinois, and completed his internship at Johns Hopkins University in Baltimore, Maryland, where he was part of the Osler Medical Service. He completed his residency training in Medicine and in Radiology at the University of Chicago, after which he was Chief of Musculoskeletal Radiology at UCSF for the following 30 years. Dr. Genant founded the Osteoporosis and Arthritis Research Group (OARG) in the Department of Radiology at UCSF in 1986, and remains its Executive Director. The OARG has been widely acclaimed as a leading source of research in noninvasive imaging methods applied to osteoporosis, arthritis and orthopedics.

Dr. Genant has edited or co-edited more than 30 text books, authored or co-authored more than 170 chapters and invited articles, nearly 500 peer-reviewed articles in scientific and medical journals, and over 1000 abstracts presented at national and international scientific and professional gatherings. He is on the editorial boards of Bone, the Journal of Spine Disorders, Osteoporosis International, the Journal of Bone and Mineral Research, and the Journal of Clinical Densitometry, and was recently named Associate Editor of Bone.

Dr. Genant is currently President-Elect of the International Skeletal Society and Chair of the WHO Task Force on Osteoporosis and Chair of the International Steering Committee for Artificial Gravity for the joint US, German and Russian Space Programs. He has served as Chair of the Scientific Committee of the First, Second, and Third International Conferences on Osteoporosis in China, and was co-chair of the Second International Conference on Osteoporosis in Japan. In 1998 he was voted Outstanding Physician of the Year by the International Society for Clinical Densitometry. Dr. Genant was also awarded honorary lifetime memberships in the American Academy of Orthopaedic Surgeons and the International Society for the Study of the Lumbar Spine. He is also an honorary member of the Chinese Osteoporosis Society, the Chilean Society of Osteology, the Hungarian Society of Osteology, and the European Society of Skeletal Radiology. He is also an Honorary Fellow of the Royal College of Radiologists.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Clinical #datamanagement is essential to ensure high-quality data in #clinicaltrials, but the components are comple… https://t.co/klK81O6YA2
Bioclinica (16 hours ago)
Congratulations to Jeff Heilbraun, M.S., VP, Medical & Scientific Affairs, for his latest article on cardiovascular… https://t.co/JSuEaeQOYh
Bioclinica (5 days ago)
Changes are a fact of life - and of #clinicaltrial design. But planning and budgeting for your trial don’t have to… https://t.co/wsfMPAwLxR
Bioclinica (3 weeks ago)
Don't compromise with manual systems and spreadsheets. As an entry-level system with phased implementation, Bioclin… https://t.co/dYDJO4Qh7S
Bioclinica (3 weeks ago)
Our webinar on Neuroimaging in Parkinson’s Disease is tomorrow at 10:30 a.m. EDT. Register at:… https://t.co/4j0FGeXG0B
Bioclinica (3 weeks ago)
Today is World Ovarian Cancer Day. Ovarian cancer has the lowest survival rate of all female cancers. #Bioclinica p… https://t.co/1nMGahTMaz
Bioclinica (4 weeks ago)